Psiac Online

Literaturverzeichnis


Webster LK. Eur J Clin Pharmacol. Jan 1984; 27(3): 341-3 Pubmed[2427]
Wedam EF. Arch Intern Med. Dec 2007; 167(22): 2469-75 Pubmed[12]
Weibrecht, Weigel. Dtsch Med Wochenschr (1976) 101, 20-2[2406]
Weigmann H. Ther Drug Monit. Aug 2001; 23(4): 410-3 Pubmed[2300]
Weiner M. Effect of centrally active drugs on the action of coumarine anticoagulants. Nature (1966) 212, 1599-1600[648]
Weintraub D. Arch Neurol. Sep 2005; 62(9): 1432-6 Pubmed[1628]
Weiss J. Eur J Pharmacol. Jan 2008; 579(1-3): 104-9 Pubmed[4475]
Weiss J. J Pharmacol Exp Ther. Apr 2003; 305(1): 197-204 Pubmed[4663]
Weiss J. Pharmaceutics. Feb 2016; 8(1) Pubmed[4439]
Wells BG. Eur J Clin Pharmacol. Jan 1986; 31(3): 285-90 Pubmed[1578]
Wempe MF. Drug Metab Dispos. Mar 2011; 39(3): 522-7 Pubmed, Volltext, DOI[263]
Wen AD. J Pharm Biomed Anal. Jan 2007; 43(2): 774-8 Pubmed[3181]
Wen B. Chem Biol Interact. Oct 2009; 181(2): 220-6 Pubmed[215]
Wen B. Drug Metab Dispos. Jul 2009; 37(7): 1557-62 Pubmed[3244]
Wen J. Biomed Chromatogr. Apr 2010; 24(4): 351-7 Pubmed[4302]
Wen X. Br J Clin Pharmacol. Nov 2001; 52(5): 547-53 Pubmed, Volltext, DOI[441]
Wen X. Drug Metab Dispos. Nov 2001; 29(11): 1359-61 Pubmed[4742]
Wen X. Eur J Clin Pharmacol. Jan 2002; 57(11): 799-804 Pubmed[961]
Wen Z. Drug Metab Dispos. Mar 2007; 35(3): 371-80 Pubmed[4687]
Wenk M. Br J Clin Pharmacol. Apr 2004; 57(4): 495-9 Pubmed, Volltext, DOI[3596]
Wenzel-Seifert et al. Psychopharmakotherapie 2013;20:148-157[984]
Wenzel-Seifert et al. Psychopharmakotherapie 2013;20:148–57[11]
Wenzel-Seifert K. Dtsch Arztebl Int. Oct 2011; 108(41): 687-93 Pubmed, Volltext, DOI[500]
Wenzel-Seifert K. Pharmacopsychiatry. Nov 2010; 43(7): 279-81 Pubmed[3517]
Werner D. Am J Cardiol. Nov 2004; 94(10): 1319-21 Pubmed[3961]
Werner U. Clin Pharmacol Ther. Aug 2003; 74(2): 130-7 Pubmed[3364]
Weschules DJ. Pain Med. Apr 2008; 9(3): 315-44 Pubmed[3423]
Wesnes K. Eur J Clin Pharmacol. Jan 1997; 52(5): 351-8 Pubmed[1790]
Wesnes KA. Br J Clin Pharmacol. Feb 2000; 49(2): 110-7 Pubmed, Volltext, DOI[2884]
West A. Adverse effects of lithium treatment. BMJ (1977) 2, 642[893]
West JM. Anesth Analg. Jul 1987; 66(7): 693-4 Pubmed[1897]
Westervelt FB Jr. JAMA. Feb 1974; 227(5): 557 Pubmed[639]
Westhervelt und Atuk (1974) JAMA 227,557[876]
Westlake RJ, Rastegar A. Hyperpyrexia from drug combinations. JAMA (1973) 225, 1250[951]
Westlake RJ, Rastegar A., JAMA (1973) 225, 1250[624]
Westphal K. Clin Pharmacol Ther. Jul 2000; 68(1): 6-12 Pubmed[4542]
Wetzels JF. Nephrol Dial Transplant. Jan 1989; 4(11): 939-42 Pubmed[1775]
Wheatley D. Arch Gen Psychiatry. Mar 1972; 26(3): 229-33 Pubmed[553]
White SI. Br J Dermatol. Jan 1996; 134(1): 188-9 Pubmed[776]
White WB. Arch Intern Med. Sep 1986; 146(9): 1833-4 Pubmed[637]
White. Lancet (1965) ii, 441[554]
Whittington HG. Am J Psychiatry. Jun 1969; 125(12): 1725-9 Pubmed[1301]
WHO. International travel and health: vaccination, requirements and health advise. Geneva : WHO 2001[1440]
WHO. International travel and health: vaccination, requirements and health advise. Geneva: WHO 2001[905]
Wiegman DJ. AIDS. Jun 2009; 23(9): 1184-5 Pubmed[3090]
Wierzbicki AS. QJM. Oct 1997; 90(10): 631-4 Pubmed[3959]
Wiesinger H. Br J Clin Pharmacol. Dec 2015; 80(6): 1399-410 Pubmed[4596]
Wietholtz H. Eur J Clin Pharmacol. Jan 1989; 36(4): 401-6 Pubmed[727]
Wigen CL. Clin Infect Dis. Jun 2002; 34(12): 1651-2 Pubmed[2025]
Wilcock GK. Lancet. Apr 1987; 1(8538): 929-30 Pubmed[2387]
Wilder BJ. Neurology. Sep 1978; 28(9 Pt 1): 892-6 Pubmed[2458]
Willcox WH. Br Med J. Mar 1920; 1(3090): 392-7 Pubmed, Volltext[663]
Willcox Wh. The nature, revention and treatment of hear pyrexia: The clinical aspect. BMJ (81920) 1, 392-7[2058]
Williams D. Clin Pharmacokinet. Jan 2002; 41(5): 343-70 Pubmed[4728]
Williams JA. Drug Metab Dispos. Nov 2002; 30(11): 1266-73 Pubmed[4671]
Williams JM. Cancer Epidemiol Biomarkers Prev. Oct 2010; 19(10): 2582-9 Pubmed, Volltext, DOI[375]
Williams SA. J Clin Psychiatry. Jan 1996; 57 Suppl 1: 7-11 Pubmed[2290]
Williamson B. Antimicrob Agents Chemother. Dec 2013; 57(12): 6366-9 Pubmed, Volltext, DOI[430]
Willmore LJ. Epilepsia. Feb 2009; 50(2): 163-73 Pubmed[2077]
Wilner et al. (1996) Eur Neuropsychopharmacol 6 (Suppl 3), 38[2498]
Wilner et al. Biol Psychiatry (1991) 29, 354S[2298]
Wilner KD, DeMattos SB, Anziano RJ, Apseloff G, Gerber N. Lack of CYP 2D6 inhibition by ziprasidone in healthy volunteers. Biol Psychiary (1997) 42, 42S[2495]
Wilner KD, Hansen RA, Folger CJ, Geoffroy P. The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid. Br J Clin Pharmacol (2000) 49 (Suppl1), 57S-60S[2493]
Wilson et al. N Engl J Med (1970) 282, 1063-1067[1590]
Windorfer A Jr. Neuropadiatrie. Feb 1977; 8(1): 29-41 Pubmed[1048]
Wingård L. J Affect Disord. Aug 2017; 217: 16-23 Pubmed[4592]
Winsemius A. J Clin Pharmacol. Sep 2014; 54(9): 1038-47 Pubmed[3960]
Winter HR. Drug Metab Dispos. Aug 2000; 28(8): 865-8 Pubmed[4453]
Winter HR. Hum Psychopharmacol. Oct 2007; 22(7): 469-76 Pubmed[2826]
Winton JC. Am J Med Sci. Feb 2013; 345(2): 160-2 Pubmed[3859]
Wiśniowska B. BMC Pharmacol Toxicol. Mar 2016; 17: 12 Pubmed, Volltext, DOI[4300]
Witt et al. Ann Pharmacother (1993) 27, 1463-4[786]
Wittmann et al. Neuro Endocrinol Lett. 2010 Apr 29;31(2):203-207[2210]
WITTON K. Am J Psychiatry. Feb 1965; 121: 812-3 Pubmed[573]
Wodak J. Med J Aust. Dec 1972; 2(23): 1277-82 Pubmed[1265]
Woelk H. Phytomedicine. Feb 2010; 17(2): 94-9 Pubmed[3638]
Wójcikowski et al. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8[1822]
Wójcikowski J. Biochem Pharmacol. Jul 2014; 90(2): 188-95 Pubmed[145]
Wójcikowski J. Biochem Pharmacol. Oct 2010; 80(8): 1252-9 Pubmed[90]
Wójcikowski J. Br J Pharmacol. Apr 2003; 138(8): 1465-74 Pubmed, Volltext, Nature[2270]
Wójcikowski J. Drug Metab Dispos. Mar 2006; 34(3): 471-6 Pubmed[214]
Wójcikowski J. Eur Neuropsychopharmacol. May 2004; 14(3): 199-208 Pubmed[177]
Wójcikowski J. Pharmacol Rep. Dec 2014; 66(6): 1122-6 Pubmed[1481]
Wójcikowski J. Pharmacol Rep. Sep 2009; 61(5): 851-8 Pubmed[422]
Wójcikowski J. Pol J Pharmacol. Jul 2002; 54(4): 407-10 Pubmed[1178]
Wójcikowski, Daniel. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8[2074]
Wojtczak A. Pharmacol Rep. Jun 2014; 66(3): 511-4 Pubmed[1441]
Wolf (2006) Drugs Res Dev 7:163-172[2794]
Wong et al. (1997) Schizophr Res 24, 200-201[2211]
Wong KE. Singapore Med J. Oct 1990; 31(5): 432-3 Pubmed[844]
Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990; 47: 640–42[2564]
Wong SL. Clin Pharmacol Ther. Jul 1996; 60(1): 48-53 Pubmed[2420]
Wong SL. Eur J Clin Pharmacol. Jan 1997; 52(3): 223-7 Pubmed[201]
Wong SL. Int J Clin Pharmacol Ther. Mar 1998; 36(3): 146-51 Pubmed[436]
Wong SL. J Clin Pharmacol. Nov 1997; 37(11): 1056-61 Pubmed[2997]
Wong YN. J Clin Pharmacol. Mar 1999; 39(3): 281-8 Pubmed[163]
Wong YWF, Ewing BJ, Thyrum PT, Yeh C. The effect of phenytoin and cimetidine on the pharmacokinetics of Seroquel. Schizophr Res (1997) 24, 200-1[2216]
Wong YWJ, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmcokinetics of quetiapine. J Clin Psychopharmacol (2001) 21, 89-93[2231]
Wood et al. Circulation (1980) 62, 119-22[1262]